I
Ivan Rios-Mondragon
Researcher at University of Bergen
Publications - 7
Citations - 138
Ivan Rios-Mondragon is an academic researcher from University of Bergen. The author has contributed to research in topics: Medicine & DNA methylation. The author has an hindex of 5, co-authored 5 publications receiving 66 citations.
Papers
More filters
Journal ArticleDOI
Microfluidics for studying metastatic patterns of lung cancer
TL;DR: The first comprehensive overview of the microfluidic systems used as innovative tools in the studies of lung cancer metastasis including single cancer cell analysis, endothelial transmigration, distant niches migration and finally neoangiogenesis is presented.
Journal ArticleDOI
Epigenetics in Breast Cancer Therapy-New Strategies and Future Nanomedicine Perspectives.
Verona Buocikova,Ivan Rios-Mondragon,Eleftherios Pilalis,Aristotelis Chatziioannou,Svetlana Miklikova,Michal Mego,Karlis Pajuste,Martins Rucins,Naouale El Yamani,Eleonora Longhin,Arkadij Sobolev,Muriel Freixanet,Víctor F. Puntes,Aiva Plotniece,Maria Dusinska,Mihaela Roxana Cimpan,Alena Gábelová,Bozena Smolkova +17 more
TL;DR: An overview of ongoing clinical trials focusing on combination therapies employing epi-drugs for breast cancer treatment is provided and the latest nano-based targeted delivery approaches forEpigenome modulation are summarized, highlighting the current limitations and obstacles associated with applying these experimental strategies in the clinics.
Journal ArticleDOI
Phosphorylation at serine 31 targets tyrosine hydroxylase to vesicles for transport along microtubules.
Ana Jorge-Finnigan,Rune Kleppe,Kunwar Jung-KC,Ming Ying,Michaël Marie,Ivan Rios-Mondragon,Michael F. Salvatore,Jaakko Saraste,Aurora Martinez +8 more
TL;DR: It is reported that THSer(P)-31 co-distributes with the Golgi complex and synaptic-like vesicles in rat and human dopaminergic cells and indicates that Ser-31 phosphorylation may regulate TH subcellular localization by enabling its transport along microtubules, notably toward the projection terminals.
Journal ArticleDOI
Decitabine potentiates efficacy of doxorubicin in a preclinical trastuzumab-resistant HER2-positive breast cancer models.
Verona Buocikova,Eleonora Longhin,Eleftherios Pilalis,Chara V. Mastrokalou,Svetlana Miklikova,Marina Cihova,Alexandra Poturnayova,Kateřina Macková,Andrea Babelova,Lenka Trnkova,Naouale El Yamani,Congying Zheng,Ivan Rios-Mondragon,Martina Labudova,Lucia Csaderova,Kristina Kuracinova,Peter J. Makovicky,Lucia Kucerova,Miroslava Matuskova,Mihaela Roxana Cimpan,Maria Dusinska,Pavel Babal,Aristotelis Chatziioannou,Alena Gábelová,Elise Rundén-Pran,Bozena Smolkova +25 more
TL;DR: In this paper , the authors investigated the ability of DNA methyltransferase (DNMT) inhibitor decitabine (DAC) to increase the sensitivity of breast cancer cells to anthracycline antibiotic doxorubicin (DOX).
Journal ArticleDOI
Novel microscopy-based screening method reveals regulators of contact-dependent intercellular transfer
Dominik Michael Frei,Erlend Hodneland,Ivan Rios-Mondragon,Anne Burtey,B Neumann,Jutta Bulkescher,Julia Schölermann,Rainer Pepperkok,Hans-Hermann Gerdes,Tanja Kögel +9 more
TL;DR: The authors' data indicates that cellular protrusions and tubular recycling endosomes are important for codeIT, and an siRNA-based screening using this method revealed the involvement of several myosins and small GTPases as codeIT regulators.